Navigation Links
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Date:8/28/2007

- Plan Extends Financial Resources Beyond 2008 -

SOUTH SAN FRANCISCO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it is reducing its workforce by approximately 25 percent, and implementing a revised operating plan that focuses its efforts on generating definitive data from its lead programs while streamlining the company's operations and extending its financial resources beyond 2008.

Based on a rigorous assessment of its product portfolio, Sunesis' top priority is the advancement of its lead product candidate, SNS-595, for the treatment of acute myeloid leukemia (AML). Having seen clinical activity and a favorable therapeutic profile in its ongoing Phase 1 single-agent clinical trial of SNS-595, Sunesis is working closely with its clinical and regulatory advisors to design a registration trial for the treatment of elderly AML patients which it plans to initiate by the end of 2008. Additionally, Sunesis will soon begin dosing patients in a Phase 1b clinical trial of relapsed AML patients, combining SNS-595 with cytarabine, the leading treatment standard.

In addition to its development activities in AML, over the next eighteen months Sunesis expects to continue to advance its ongoing studies of SNS-595 in ovarian cancer, SNS-032 in B-cell malignancies and SNS-314 in solid tumors.

Positive data from any of these studies could support registration strategies or one or more significant development-stage collaborations. Sunesis' refocused research team will continue to generate insights on the chemistry and biology of the company's product candidates that may inform and guide clinical trials, to advance novel, small molecule i
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...nalysisandForecaststo2013 ,, http://www.repor...ysis-and-Forecasts-to-2013.html ,, BrazilBioet...ry ,, Thereportprovidesdetailedanalysisandfore...anolmarketinparticular.Italsohelpsinanalyzingandfo...
(Date:11/24/2009)...ent bank KTA Capital,s client Neuren Pharmaceutica...ble note private placement with a U.S. institution... KTA Capital as Neuren,s exclusive placement agent...(PRWEB) November 23, 2009 -- The independent New Y...pital") has announced that its client Neuren ...
(Date:11/24/2009)...ent grew by 29,000 jobs in October, and the field...ring the U.S. recession. However, clinics and spec...ems are coming closer to having to actually cut me..., (Vocus) November 24, 200...ctober despite the shedding of jobs in most other ...
(Date:11/24/2009)...EnergyCorp.announcedtodaythatthecompanyandtheOdess...ed$2millionbyWashingtonState,sCommunityEconomicRev...toconstructthestate,sfirstspecialtybiochemicalbior...llsignificantlyspeedthedevelopmentofourbiorefinery...rbleEnergyCEOKellyOgilvie."WearegratefultotheGover...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...nced,today that the Chicago Athenaeum Museum of Ar...GN(TM) Award for the new SoloSTAR(R) disposable,in...e 2 diabetes., "LANTUS(R) SoloSTAR(R) and APIDRA(...intensive development, have been designed in dialo... high standards of the industry,",said Paul Jansen...
...may Lead to Improved Vaccine Against Leadi...France, February 14 Sanofi pasteur, the,vaccines ...day that it has,signed a collaborative research an...t of Denmark (SSI) for the development and marketi...isease that causes the death of two,million people...
...ping the perfect complement to the power tie: a po...all electronic devices for soldiers in the field, ...arnessed and converted to electrical energy. , Th...how pairs of textile fibers covered with zinc oxid...the piezoelectric effect. Combining current flow ...
Other Biology Technology:Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 2Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 3Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 5Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 2Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 3Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis 4Fiber-based nanotechnology in clothing could harvest energy from physical movement 2Fiber-based nanotechnology in clothing could harvest energy from physical movement 3Fiber-based nanotechnology in clothing could harvest energy from physical movement 4
(Date:11/24/2009)... atomic-level action of a remarkable class of ring...rchers with the Lawrence Berkeley National Laborat...n crystallography beamline at the Advanced Light S...es in gene expression and replication, and are vit...l as infectious agents, such as the human papillom...
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
(Date:11/24/2009)...is release is available in Spanish . , The ...er levels of inflammatory substances in the blood,...as shown by a research project of the University o... scientist at the School of Pharmacy. , The proj...dy in relation to the control of body weight and i...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2Lotus Pharmaceuticals Inc to Exhibit at the 2009 International Conference for Bioeconomy 49247 1Lotus Pharmaceuticals Inc to Exhibit at the 2009 International Conference for Bioeconomy 49247 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 1Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 3Telemedicine expands reach of care for Parkinsons patients 49238 1Telemedicine expands reach of care for Parkinsons patients 49238 2Telemedicine expands reach of care for Parkinsons patients 49238 3
...etarian and vegan diets are healthful choices for ... needs can be easily met with fortified foods or a... with the Physicians Committee for Responsible Med... for comment in response to a new Pediatrics stu...ease the risk for neural tube defects. , The Pe...
... there are important considerations to the success... environment, regular hormonal injections and the ...ome of an in-vitro procedure. , Now a Tel Aviv U...e parents and their obstetricians also look at the...es play in its success. New studies by Prof. David...
...09 >> Genomatix Software, a leading provid...Generation Sequencing (NGS) data, announced today ...talled a Genomatix Mining Station and a Genomatix ...iberach, Germany. These systems deliver the only c...ata, from the raw data generated by the sequencer,...
Other Biology News:Doctors endorse vegan and vegetarian diets for healthy pregnancies 2Engineering bouncing babies, 1 at a time 2Boehringer Ingelheim uses Genomatix' Next Generation Sequencing data analysis systems 2
Varian 2200 Ion Trap GC/MS from Varian, Inc.
...ses a simplified procedure and streamlines the bis...t is based on the three step reaction that takes p...ytosine is converted into uracil. The EZ DNA Methy...action eliminates several precipitation steps and ...
...s are intended for laboratory research use only. ...red formalin and embedded in paraffin. Tissue ide...ed pathologists. Tissue cores were removed from t...pient paraffin block, in an array pattern, using C...
...s are intended for laboratory research use only. ...red formalin and embedded in paraffin. Tissue ide...ed pathologists. Tissue cores were removed from t...pient paraffin block, in an array pattern, using C...
Biology Products: